Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin + transdermal buprenorphine versus pregabalin + diclofenac in chronic peripheral neuropathic pain
2008-002131-32Phase 3Active
- Sponsor
- Associazione Italiana per lo Studio del Dolore
- Start
- May 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Peripheral neuropathic pain, postherpetic neuralgia (PHN) and diabetic polyneuropathy (DPN) comparing Pregabalin + transdermal buprenorphine with Pregabalin + diclofenac (2 arms). Primary endpoint: Time spent in randomized treatment group during the expected observation period. Started May 2008; status: active.
02
Drugs
pregabalinbuprenorphinediclofenac
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2008-002131-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002131-32.